According to Renovaro Biosciences's latest financial reports the company's current earnings (TTM) are -A$80.89 M. In 2023 the company made an earning of -A$61.85 M an increase over its 2022 earnings that were of -A$0.17 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.